![](/img/cover-not-exists.png)
Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers, W, Foidart, J M, Dombrovicz, N, Welter, A, Heithecker, RVolume:
80
Language:
english
Journal:
The Journal of Clinical Endocrinology & Metabolism
DOI:
10.1210/jcem.80.6.7775629
Date:
June, 1995
File:
PDF, 769 KB
english, 1995